发明名称 RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION
摘要 The present invention relates to oligomer compounds (oligomers), which target PIK3CA mRNA in a cell, leading to reduced expression of PIK3CA. Reduction of PIK3CA expression is beneficial for the treatment of certain medical disorders, such as hyperproliferative diseases such as cancer.
申请公布号 WO2009071082(A3) 申请公布日期 2009.07.30
申请号 WO2008DK00418 申请日期 2008.11.26
申请人 SANTARIS PHARMA A/S;HEDT JAARN, MAJ 发明人 HEDT JAARN, MAJ
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项
地址